ACR24 - Day2a
Rheumnow Podcast
00:00
Intro
This chapter explores the long-term benefits of bimikizumab on the quality of life for psoriatic arthritis patients, referencing findings from Abstract 600. It highlights the importance of the PSA-12 measure in assessing pain and emotional well-being, revealing sustained improvement in patient health over one to two years.
Transcript
Play full episode
